Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa

Article

Abstract: Introduction: Dolutegravir is being scaled up globally as part of antiretroviral therapy (ART), but

Palabras claves:

antiretroviral agents, antitubercular agents, drug interactions, HIV integrase inhibitors, Observational Study, rifampin

Autores:

Brazier E., Chimbetete C., De Waal R., Diero L., Dzudie A., Ezechi O.C., Fenner L., Kunzekwenyika C., Lelo P., Mahambou-Nsondé D., Matthew L. Romo, Muhairwe J.A., Murenzi G., Muyindike W.R., Nash D., Rafael I., Sekaggya-Wiltshire C., Shah N.S., Tiendrebeogo T., Twizere C., Wools-Kaloustian K.K., Yotebieng M.

Fuentes:

scopus